Literature DB >> 2930626

Quinazoline antifolates inhibiting thymidylate synthase: computer modelling of the N10 substituent.

T R Jones1, R F Betteridge, S Neidle, A L Jackman, A H Calvert.   

Abstract

The synthesis and biological properties of N10-(2,2,2-trifluoroethyl)-5, 8-dideazafolic acid are described. It was fivefold less active as an inhibitor of L1210 thymidylate synthase (TS) than its N10-ethyl congener and sevenfold less active as an inhibitor of the growth of L1210 cells in culture. CNDO calculations were performed on the following N10 substituents in a model fragment of 5, 8-dideazafolic acid: propargyl, ethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, cyanomethyl and methyl. The resulting values of partial charge on the distal terminus of the substituent correlated with the TS inhibition induced by the substituent. In particular, the mildly net positive charge on the acetylenic hydrogen in the propargyl substituent (+0.064) was not matched by any other in the series. N10-propargyl-5, 8-dideazafolic acid continues as the best inhibitor in this series.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2930626

Source DB:  PubMed          Journal:  Anticancer Drug Des        ISSN: 0266-9536


  3 in total

1.  Antibacterial effects of trisubstituted quinazoline derivatives.

Authors:  S Jantová; G Greif; K Spirková; S Stankovský; M Oravcová
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

2.  Comparative cytotoxicity of folate-based inhibitors of thymidylate synthase and 5-fluorouracil +/- leucovorin in MGH-U1 cells.

Authors:  C Erlichman; B Mitrovski
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Biochemical effects of folate-based inhibitors of thymidylate synthase in MGH-U1 cells.

Authors:  B Mitrovski; J Pressacco; S Mandelbaum; C Erlichman
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.